Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

about

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

Item

http://www.wikidata.org/entity/Q47784630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@en

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@nl

type

Item

label

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@en

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@nl

prefLabel

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@en

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@nl

P1476

Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

@en

P2093

Frank P Vleggaar

http://www.w3.org/2001/XMLSchema#string

Nadia Haj Mohammad

http://www.w3.org/2001/XMLSchema#string

Peter S N van Rossum

http://www.w3.org/2001/XMLSchema#string

P2860

Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis

Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

P2888

nrgastro.2017.162

P31

scholarly article

review article

P356

10.1038/NRGASTRO.2017.162

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Richard van Hillegersberg

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29235549

http://www.w3.org/2001/XMLSchema#string